Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutathione in Parkinson's Disease
NCT01177319Phase 2Completed
- Sponsor
- University of South Florida
- Start
- Sep 2003
- Primary completion
- Mar 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Glutathione with Placebo (2 arms). Primary endpoints: Timed walking test at 12 weeks and Tapping test at 12 weeks. Started Sep 2003; status: completed.
02
Drugs
glutathione
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01177319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01177319.